{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:27:06Z","timestamp":1772148426997,"version":"3.50.1"},"reference-count":63,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/j.psychres.2020.113591","type":"journal-article","created":{"date-parts":[[2020,11,24]],"date-time":"2020-11-24T20:53:34Z","timestamp":1606251214000},"page":"113591","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer's disease: A naturalistic and multicenter study"],"prefix":"10.1016","volume":"295","author":[{"given":"Larissa de Freitas","family":"Oliveira","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einstein Francisco","family":"Camargos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luciana Lilian Louzada","family":"Martini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fl\u00e1vio Vieira","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria Rita Carvalho Garbi","family":"Novaes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.psychres.2020.113591_bib0001","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-012759","article-title":"Systematic review of systematic reviews of non-pharmacological interventions to treat behavioural disturbances in older patients with dementia. The SENATOR-OnTop series","volume":"7","author":"Abraha","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/j.psychres.2020.113591_bib0002","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s40266-019-00668-7","article-title":"Current agents in development for treating behavioral and psychological symptoms associated with dementia","volume":"36","author":"Ahmed","year":"2019","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0003","article-title":"The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","author":"Association","year":"2016","journal-title":"Am. Psychiatr. Assoc."},{"key":"10.1016\/j.psychres.2020.113591_bib0004","series-title":"Diagnostic and Statistical Manual of Mental Disorders: DSM-5","first-page":"c2013","year":"2013"},{"key":"10.1016\/j.psychres.2020.113591_bib0005","first-page":"1","article-title":"A systematic review of atypical antipsychotic drugs in schizophrenia","volume":"7","author":"Bagnall","year":"2003","journal-title":"Health Technol. Assess. (Rockv)"},{"key":"10.1016\/j.psychres.2020.113591_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta17070","article-title":"Study of the use of antidepressants for depression in dementia: the HTA-SADD trial\u2013a multicentre, randomised, double-blind, placebo-controlled trial of the clinical effectiveness and cost-effectiveness of sertraline and mirtazapine","volume":"17","author":"Banerjee","year":"2013","journal-title":"Health Technol. Assess. (Rockv)."},{"key":"10.1016\/j.psychres.2020.113591_bib0007","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2147\/CIA.S218641","article-title":"Determinants of antipsychotic drugs prescription among community-living older adults with dementia: a population-based study using health information systems in the Lazio Region, Italy","volume":"14","author":"Bargagli","year":"2019","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0008","article-title":"The prevalence and the course of neuropsychiatric symptoms in patients with dementia","volume":"22","author":"Bergh","year":"2012","journal-title":"Nor. Epidemiol.."},{"key":"10.1016\/j.psychres.2020.113591_bib0009","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11920-019-1049-5","article-title":"Management of behavioral and psychological symptoms of dementia","volume":"21","author":"Bessey","year":"2019","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2020.113591_bib0010","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1471-2318-14-32","article-title":"Neuropsychiatric symptoms in patients with dementia in primary care: a study protocol","volume":"14","author":"Borsje","year":"2014","journal-title":"BMC Geriatr"},{"key":"10.1016\/j.psychres.2020.113591_bib0011","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2147\/NDT.S3201","article-title":"The efficacy of mirtazapine in agitated patients with Alzheimer’s disease: a 12-week open-label pilot study","volume":"4","author":"Cakir","year":"2008","journal-title":"Neuropsychiatr. Dis. Treat."},{"key":"10.1016\/j.psychres.2020.113591_bib0012","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2019.01465","article-title":"The use of antipsychotic drugs for treating behavioral symptoms in Alzheimer's disease","volume":"10","author":"Calsolaro","year":"2019","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.psychres.2020.113591_bib0013","article-title":"Treatment effects between monotherapy of donepezil versus combination with memantine for Alzheimer disease: a meta-analysis","volume":"12","author":"Chen","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2020.113591_bib0014","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1080\/14737175.2018.1476140","article-title":"The modern role of antipsychotics for the treatment of agitation and psychosis in Alzheimer's disease","volume":"18","author":"Creese","year":"2018","journal-title":"Expert Rev. Neurother."},{"key":"10.1016\/j.psychres.2020.113591_bib0015","doi-asserted-by":"crossref","first-page":"10S","DOI":"10.1212\/WNL.48.5_Suppl_6.10S","article-title":"The neuropsychiatric inventory: assessing psychopathology in dementia patients","volume":"48","author":"Cummings","year":"1997","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2020.113591_bib0016","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1177\/0269881117744996","article-title":"Sequential drug treatment algorithm for agitation and aggression in Alzheimer's and mixed dementia","volume":"32","author":"Davies","year":"2018","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.psychres.2020.113591_bib0017","doi-asserted-by":"crossref","DOI":"10.1093\/ijnp\/pyv055","article-title":"Use of benzodiazepines in Alzheimer's disease: a systematic review of literature","volume":"18","author":"Defrancesco","year":"2015","journal-title":"Int. J. Neuropsychopharmacol."},{"key":"10.1016\/j.psychres.2020.113591_bib0018","doi-asserted-by":"crossref","first-page":"34","DOI":"10.5327\/Z2447-2115201500010007","article-title":"Neuropsychiatric symptoms among elderly people with Alzheimer disease and caregivers\u2019 behaviors","volume":"9","author":"Delfino","year":"2015","journal-title":"Geriatr. Gerontol. Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0019","first-page":"81","article-title":"Contributo para a valida\u00e7\u00e3o concorrente de uma medida de ades\u00e3o aos tratamentos","volume":"2","author":"Delgado","year":"2001","journal-title":"Psicol. Sa\u00fade e Doen\u00e7as"},{"key":"10.1016\/j.psychres.2020.113591_bib0020","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3233\/JAD-122140","article-title":"A meta-analysis of the efficacy of donepezil, rivastigmine, galantamine, and memantine in relation to severity of Alzheimer's disease","volume":"35","author":"Di Santo","year":"2013","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.psychres.2020.113591_bib0021","unstructured":"Equipe T\u00e9cnica do N\u00facleo de Sa\u00fade do Idoso, 2014. Protocolo de Aten\u00e7\u00e3o \u00e0 Sa\u00fade-Antidepressivos em Idosos\u00a0: Citalopram e Mirtazapina [WWW Document]. Comiss\u00e3o Perm. Protoc. Aten\u00e7\u00e3o \u00e0 Sa\u00fade da SES-DF -. URL http:\/\/www.saude.df.gov.br\/wp-conteudo\/uploads\/2018\/04\/5.2_PDF_Antidepressivos_em_Idosos_-_Citalopram_e_Mirtazapina_1.pdf (accessed 4.19.20)."},{"key":"10.1016\/j.psychres.2020.113591_bib0022","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40266-014-0154-8","article-title":"Anti-dementia drugs and co-medication among patients with Alzheimer's disease","volume":"31","author":"Fereshtehnejad","year":"2014","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0023","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s40265-014-0293-6","article-title":"Antiepileptic drugs for the treatment of agitation and aggression in dementia: do they have a place in therapy?","volume":"74","author":"Gallagher","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/j.psychres.2020.113591_bib0024","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/gps.1949","article-title":"Improvement in behavioural symptoms in patients with moderate to severe Alzheimer's disease by memantine: a pooled data analysis","volume":"23","author":"Gauthier","year":"2008","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0025","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jcgg.2015.06.001","article-title":"Successful treatment of agitation and aggression with prazosin in an elderly patient with dementia and comorbid heart disease","volume":"7","author":"Greve","year":"2016","journal-title":"J. Clin. Gerontol. Geriatr."},{"key":"10.1016\/j.psychres.2020.113591_bib0026","doi-asserted-by":"crossref","first-page":"h369","DOI":"10.1136\/bmj.h369","article-title":"Assessment and management of behavioral and psychological symptoms of dementia","volume":"350","author":"Kales","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/j.psychres.2020.113591_bib0027","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/gps.4405","article-title":"The comparative efficacy and safety of cholinesterase inhibitors in patients with mild-to-moderate Alzheimer's disease: a Bayesian network meta-analysis","volume":"31","author":"Kobayashi","year":"2016","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0028","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11920-015-0640-7","article-title":"Agitation and irritability in Alzheimer's disease: evidenced-based treatments and the black-box warning","volume":"18","author":"Koenig","year":"2016","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2020.113591_bib0029","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.apnu.2006.04.004","article-title":"Outcomes of antipsychotic drug use in community-dwelling elders with dementia","volume":"20","author":"Kolanowski","year":"2006","journal-title":"Arch. Psychiatr. Nurs."},{"key":"10.1016\/j.psychres.2020.113591_bib0030","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/j.trci.2017.07.001","article-title":"Neuropsychiatric signs and symptoms of Alzheimer\u2019s disease: new treatment paradigms","volume":"3","author":"Lanct\u00f4t","year":"2017","journal-title":"Alzheimer\u2019s Dement. Transl. Res. Clin. Interv."},{"key":"10.1016\/j.psychres.2020.113591_bib0031","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1176\/appi.ajp.2016.15020248","article-title":"Effects of citalopram on neuropsychiatric symptoms in Alzheimer's dementia: Evidence from the CitAD study","volume":"173","author":"Leonpacher","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0032","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1590\/S0102-311X2008000100010","article-title":"Adapta\u00e7\u00e3o transcultural da Escala de Independ\u00eancia em Atividades da Vida Di\u00e1ria (Escala de Katz)","volume":"24","author":"Lino","year":"2008","journal-title":"Cad. Saude Publica"},{"key":"10.1016\/j.psychres.2020.113591_bib0033","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1192\/bjp.bp.113.141119","article-title":"Non-pharmacological interventions for agitation in dementia: systematic review of randomised controlled trials","volume":"205","author":"Livingston","year":"2014","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0034","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1590\/S0034-89102005000600007","article-title":"Validade da vers\u00e3o em portugu\u00eas da clinical dementia rating","volume":"39","author":"Macedo Monta\u00f1o","year":"2005","journal-title":"Rev. Saude Publica"},{"key":"10.1016\/j.psychres.2020.113591_bib0035","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1001\/jama.2011.1360","article-title":"Efficacy and comparative effectiveness of atypical antipsychotic medications for off-label uses in adults","volume":"306","author":"Maher","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2020.113591_bib0036","doi-asserted-by":"crossref","first-page":"P859","DOI":"10.1016\/j.jalz.2014.05.1710","article-title":"Combination therapy with cholinesterase inhibitors and memantine for Alzheimer's disease: systematic review and meta-analysis","volume":"10","author":"Matsunaga","year":"2014","journal-title":"Alzheimer's Dement"},{"key":"10.1016\/j.psychres.2020.113591_bib0037","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1002\/gps.4452","article-title":"Psychotropic use and associated neuropsychiatric symptoms among patients with dementia in the USA","volume":"32","author":"Maust","year":"2017","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0038","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13670-019-0269-1","article-title":"Pharmacologic management of agitation in patients with dementia","volume":"8","author":"McDermott","year":"2019","journal-title":"Curr. Geriatr. Rep."},{"key":"10.1016\/j.psychres.2020.113591_bib0039","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1212\/WNL.34.7.939","article-title":"Clinical diagnosis of Alzheimer\u2019s disease: report of the NINCDS-ADRDA Work Group* under the auspices of department of health and human services task force on Alzheimer\u2019s disease","volume":"34","author":"McKhann","year":"1984","journal-title":"Neurology"},{"key":"10.1016\/j.psychres.2020.113591_bib0040","doi-asserted-by":"crossref","first-page":"15","DOI":"10.2165\/00002512-199915010-00002","article-title":"Drug-induced cognitive impairment in the elderly","volume":"15","author":"Moore","year":"1999","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0041","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1017\/S1041610209008916","article-title":"Prevalence and correlates of psychotropic drug use in Dutch nursing-home patients with dementia","volume":"21","author":"Nijk","year":"2009","journal-title":"Int. Psychogeriatrics"},{"key":"10.1016\/j.psychres.2020.113591_bib0042","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13195-015-0096-3","article-title":"Principles and management of neuropsychiatric symptoms in Alzheimer's dementia","volume":"7","author":"Nowrangi","year":"2015","journal-title":"Alzheimers. Res. Ther."},{"key":"10.1016\/j.psychres.2020.113591_bib0043","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2165\/00002512-200825010-00007","article-title":"Benzodiazepines and Injurious falls in community dwelling elders","volume":"25","author":"Pariente","year":"2008","journal-title":"Drugs Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0044","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s40268-019-0272-1","article-title":"Neuropsychiatric symptoms in dementia: considerations for pharmacotherapy in the USA","volume":"19","author":"Phan","year":"2019","journal-title":"Drugs R D"},{"key":"10.1016\/j.psychres.2020.113591_bib0045","doi-asserted-by":"crossref","first-page":"39","DOI":"10.5327\/Z2447-211520191800055","article-title":"Cognitive stimulation in older adults with dementia: what is the impact on their caregivers\u2019 health?","volume":"13","author":"Pinto","year":"2019","journal-title":"Geriatr. Gerontol. Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0046","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1001\/jama.2014.93","article-title":"Effect of citalopram on agitation in Alzheimer disease","volume":"311","author":"Porsteinsson","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.psychres.2020.113591_bib0047","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0160768","article-title":"Risk of ventricular arrhythmia with citalopram and escitalopram: a population-based study","volume":"11","author":"Qirjazi","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.psychres.2020.113591_bib0048","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1176\/appi.ajp.2015.173501","article-title":"The American psychiatric association practice guideline on the use of antipsychotics to treat agitation or psychosis in patients with dementia","volume":"173","author":"Reus","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0049","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1016\/j.eurpsy.2004.09.031","article-title":"Grouping for behavioral and psychological symptoms in dementia: clinical and biological aspects. Consensus paper of the European Alzheimer disease consortium","volume":"20","author":"Robert","year":"2005","journal-title":"Eur. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0050","doi-asserted-by":"crossref","first-page":"290","DOI":"10.5020\/18061230.2008.p290","article-title":"Confiabilidade da vers\u00e3o brasileira da Escala de Atividades Instrumentais da Vida Di\u00e1ria","author":"Santos","year":"2008","journal-title":"Rev. Bras. em Promo\u00e7\u00e3o da Sa\u00fade"},{"key":"10.1016\/j.psychres.2020.113591_bib0051","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/01.JGP.0000200589.01396.6d","article-title":"Efficacy and adverse effects of atypical antipsychotics for dementia: meta-analysis of randomized, placebo-controlled trials","volume":"14","author":"Schneider","year":"2006","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0052","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1176\/appi.ajp.2015.15050648","article-title":"Heterogeneity of treatment response to citalopram for patients with Alzheimer's disease with aggression or agitation: the CitAD randomized clinical trial","volume":"173","author":"Schneider","year":"2016","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0053","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008191.pub2","article-title":"Antidepressants for agitation and psychosis in dementia","author":"Seitz","year":"2011","journal-title":"Cochrane Database Syst. Rev."},{"key":"10.1016\/j.psychres.2020.113591_bib0054","doi-asserted-by":"crossref","first-page":"126","DOI":"10.5327\/Z2447-211520191900035","article-title":"Unavailability of appropriate doses and need for tablet splitting of psychotropic drugs by geriatric patients","volume":"13","author":"Starling","year":"2019","journal-title":"Geriatr. Gerontol. Aging"},{"key":"10.1016\/j.psychres.2020.113591_bib0055","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S1516-44462002000500005","article-title":"Tratamento dos transtornos do comportamento de pacientes com dem\u00eancia","volume":"24","author":"Tamai","year":"2002","journal-title":"Rev. Bras. Psiquiatr."},{"key":"10.1016\/j.psychres.2020.113591_bib0056","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1177\/1533317514524813","article-title":"Efficacy and Tolerability of benzodiazepines for the treatment of behavioral and psychological symptoms of dementia","volume":"29","author":"Tampi","year":"2014","journal-title":"Am. J. Alzheimer's Dis. Other Dementiasr"},{"key":"10.1016\/j.psychres.2020.113591_bib0057","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1177\/2040622316658463","article-title":"Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses","volume":"7","author":"Tampi","year":"2016","journal-title":"Ther. Adv. Chronic Dis."},{"key":"10.1016\/j.psychres.2020.113591_bib0058","doi-asserted-by":"crossref","first-page":"615","DOI":"10.3233\/JAD-132690","article-title":"Efficacy and safety of donepezil, galantamine, rivastigmine, and memantine for the treatment of Alzheimer's disease: a systematic review and meta-analysis","volume":"41","author":"Tan","year":"2014","journal-title":"J. Alzheimer's Dis."},{"key":"10.1016\/j.psychres.2020.113591_bib0059","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/j.jamda.2017.06.010","article-title":"Efficacy and safety of citalopram compared to atypical antipsychotics on agitation in nursing home residents with Alzheimer dementia","volume":"18","author":"Viscogliosi","year":"2017","journal-title":"J. Am. Med. Dir. Assoc."},{"key":"10.1016\/j.psychres.2020.113591_bib0060","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1002\/gps.5223","article-title":"Pathways to care for people with dementia: an international multicentre study","volume":"35","author":"Volpe","year":"2020","journal-title":"Int. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0061","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1097\/JGP.0b013e3181ab8c61","article-title":"Prazosin for the treatment of behavioral symptoms in patients with Alzheimer disease with agitation and aggression","volume":"17","author":"Wang","year":"2009","journal-title":"Am. J. Geriatr. Psychiatry"},{"key":"10.1016\/j.psychres.2020.113591_bib0062","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11920-018-0978-8","article-title":"Diagnosis and management of neuropsychiatric symptoms in Alzheimer's disease","volume":"20","author":"Wolinsky","year":"2018","journal-title":"Curr. Psychiatry Rep."},{"key":"10.1016\/j.psychres.2020.113591_bib0063","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1001\/jama.2017.11112","article-title":"Antipsychotics to treat agitation or psychosis in patients with dementia","volume":"318","author":"Yohanna","year":"2017","journal-title":"JAMA"}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120332522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178120332522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T05:41:25Z","timestamp":1759038085000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178120332522"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":63,"alternative-id":["S0165178120332522"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113591","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of psychotropic agents to treat agitation and aggression in Brazilian patients with Alzheimer's disease: A naturalistic and multicenter study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2020.113591","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113591"}}